
Exploring Epidermolytic Palmoplantar Keratoderma: The Role of Genetic Testing
Uncover how genetic testing aids in diagnosing Epidermolytic Palmoplantar Keratoderma, a rare skin disorder marked by thickened skin on palms and soles.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uncover how genetic testing aids in diagnosing Epidermolytic Palmoplantar Keratoderma, a rare skin disorder marked by thickened skin on palms and soles.

Uncover how genetic testing aids in managing familial erythroleukemia, focusing on early detection, personalized treatment, and informed family planning decisions.

Explore how genetic testing identifies risks in essential hypertension, offering personalized treatment plans and early interventions to manage this silent killer.

Reveal the impact of genetic testing in managing euthyroid goiter, from decoding genetic predispositions to enhancing diagnostic accuracy and guiding treatments.

Hereditary multiple exostoses (HME) involves benign bone tumors. Genetic testing aids early detection, managing symptoms, and guiding family planning decisions.

Explore how genetic testing confirms exostoses type 2, predicts disease progression, and aids family planning, uncovering crucial insights for better management.

Genetic testing reveals CAPSL gene's role in Exudative Vitreoretinopathy 1, enabling early diagnosis, personalized treatment, and informed genetic counseling.

Unlock the benefits of genetic testing in diagnosing familial cylindromatosis, from early detection and personalized treatment to family planning and research insights.